Institution statistics

EUROPEAN ORGANISATION FOR RARE DISEASES - France 

Ranking results:

Past rankings:
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding:600-700
Total Project Funding per Partner:> 1000
Total Number of Projects:69
Networking Rank (Reputation):600-700
Networking Rank (Reputation):600-700
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 10
As coordinator: 1
As participant: 9
Sole participant: 0
Coordinator / Participant Ratio: 0.11*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 9.640.775 625.908 1
2018 0 4.498.931 463.597 1
2016 0 3.836.996 0 1
2015 0 2.325.106 150.544 2
2013 0 2.000.000 168.000 1
2012 0 19.997.042 561.677 2
2007 154.581 10.000.000 401.287 1 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KAROLINSKA INSTITUTE4
ISTITUTO SUPERIORE DI SANITA3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
UNIVERSITY OF NEWCASTLE UPON TYNE3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FONDAZIONE TELETHON2
INSTITUTO DE SALUD CARLOS III2
LEIDEN UNIVERSITY MEDICAL CENTER2
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVARTIS PHARMA2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
UNIVERSITAET ZUERICH2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE D'AIX MARSEILLE2
UNIVERSITEIT MAASTRICHT2
UNIWERSYTET JAGIELLONSKI2
UPPSALA UNIVERSITET2
ZORGINSTITUUT NEDERLAND2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACIES SAS1
AGENZIA ITALIANA DEL FARMACO1
AIBILII ASSOCIACAO DE APOIOAO INSTITUTO BIOMEDICO DE INVESTIGACAO DA LUZ E IMAGEM1
ALEXION SERVICES EUROPE SPRL1
ALZHEIMER EUROPE1
AMGEN LIMITED1
ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOCRUCES1
ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES1
ASSOCIAZIONE PER LA RICERCA SULLA EFFICACIA DELLA ASSISTENZA SANITARIA CENTRO COCHRANE ITALIANO1
ASTEX1
ASTRAZENECA AB1
BAYER AKTIENGESELLSCHAFT1
BIOLOGIS GENETIC INFORMATION MANAGEMENT1
BULGARIAN ASSOCIATION FOR PROMOTION OF EDUCATION AND SCIENCE1
CARTAGENIA NV1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCIO DE APOYO A LA INVESTIGACION BIOMEDICA EN RED1
CONSORZIO ITALIANO PER LA RICERCA IN MEDICINA1
COVANCE LABORATORIES1
DANISH HEALTH AND MEDICINES AUTHORITY1
DEPARTMENT OF HEALTH GOVERNMENT OF WESTERN AUSTRALIA1
DOKUZ EYLUL UNIVERSITESI1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EGESZSEGUGY MINISZTERIUMI1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELI LILLY AND COMPANY LIMITED1
ENAMINE LIMITED LIABILITY COMPANYRESEARCH AND PRODUCTION ENTERPRISE1
ESPENLA SOCIETE EUROPEENNE DE NUTRITION CLINIQUE ET METABOLISME ASBL1
EUROPEAN ACADEMY OF PAEDIATRICS AISBL1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EUROPEAN MEDICINES AGENCY1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN NEUROMUSCULAR CENTRE1
EUROPEAN PATIENTS' FORUM1
F HOFFMANNLA ROCHE1
FACULDADE DE CIENCIAS MEDICAS DA UNIVERSIDADE NOVA DE LISBOA1
FEDERACION ESPANOLA DE ENFERMEDADES RARAS1
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES1
FINNMEDI OY1
FINOVATIS1
FODOR JOZSEF NATIONAL CENTER FOR PUBLIC HEALTH1
FONDATION MALADIES RARES1
FORUM DES PATIENS EUROPEENS ASBL EUROPEAN PATIENTS FORUM FPE EPF1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA1
FUNDACIO SANT JOAN DE DEU1
FUNDACION CANARIA DE INVESTIGACION Y SALUD1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GENETHON1
GENOSAFE SAS1
GIOTTO BIOTECH1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GRUENENTHAL1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
H LUNDBECK AS1
HAUTE AUTORITE DE SANTE1
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY1
HEALTHCARE IMPROVEMENT SCOTLAND1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HUNGAROTRIAL GYOGYSZERKUTATASI SZOLGALTATO ZARTKORUEN MUKODO RESZVENYTARSASAG1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOLYST INC CORPORATION PATIENTCROSSROADS1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE1
INSTITUT PASTEUR1
INSTITUTET FOR FREMTIDSFORSKNING FORENING1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA UNIVERSIDADE NOVA DE LISBOA1
INTERACTIVE BIOSOFTWARE SARL1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
JAMARAU1
JANSSEN PHARMACEUTICA NV1
KING'S COLLEGE LONDON1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LANDSPITALI UNIVERSITY HOSPITAL1
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
Constancy:

Total number of partners:208

Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 191

Frequent / Rare Partner Ratio: 0.09

Diversity:

Categories:
Category:No:
RTD HORIZONTAL TOPICS4
SOCIAL AND ECONOMIC CONCERNS1
BIOLOGICAL SCIENCES1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe HTxparticipant9.640.77515
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2016-01-01Accelerated Early staGe drug diScovery AEGISparticipant3.836.99626
2015-09-03Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes ADAPT-SMARTparticipant1.130.00010
2015-01-01A stepping stone approach towards the Genetics Clinic of the Future GCOFparticipant1.195.10612
2013-01-01Platform for sharing best practices for management of rare diseases RARE-BESTPRACTICESparticipant2.000.00015
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-01-01European Clinical Research Infrastructures Network - Integrating Activity ECRIN-IAparticipant7.999.93147
2007-01-01Translational research in Europe - Assessment and treatment of neuromuscular diseases TREAT-NMDparticipant10.000.00027
2007-01-01Capacity-building for patient organisations to participate in Research Activities CAPOIRAcoordinator154.5815

Alias institution names:
  • EUROPEAN ORGANISATION FOR RARE DISEASES

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum